These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 1496971

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of protease therapy in the remnant kidney model of progressive renal failure.
    Sebekova K, Paczek L, Dämmrich J, Ling H, Spustova V, Gaciong Z, Heidland A.
    Miner Electrolyte Metab; 1997; 23(3-6):291-5. PubMed ID: 9387136
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.
    Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr S.
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):193-7. PubMed ID: 3855542
    [Abstract] [Full Text] [Related]

  • 27. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.
    Patel A, Layne S, Watts D, Kirchner KA.
    Hypertension; 1993 Dec; 22(6):863-9. PubMed ID: 8244518
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K, Usami T, Kamiya Y, Kamiya T, Yoshida A, Itoh S, Yamato H, Ise M, Kimura G.
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [Abstract] [Full Text] [Related]

  • 33. N-acetylcysteine attenuates the progression of chronic renal failure.
    Shimizu MH, Coimbra TM, de Araujo M, Menezes LF, Seguro AC.
    Kidney Int; 2005 Nov; 68(5):2208-17. PubMed ID: 16221220
    [Abstract] [Full Text] [Related]

  • 34. Dietary L-arginine supplementation improves the glomerular filtration rate and renal blood flow after 24 hours of unilateral ureteral obstruction in rats.
    Ito K, Chen J, Vaughan ED, Seshan SV, Poppas DP, Felsen D.
    J Urol; 2004 Feb; 171(2 Pt 1):926-30. PubMed ID: 14713855
    [Abstract] [Full Text] [Related]

  • 35. Renal vascular structural properties and their alterations by removal of uraemic toxins in a rat model of chronic kidney disease.
    Yamazaki H, Tomoda F, Koike T, Kinuno H, Sugimori H, Inoue H, Bannai K, Sugano M, Nishijima F.
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):238-45. PubMed ID: 24471839
    [Abstract] [Full Text] [Related]

  • 36. Can L-arginine manipulation reduce renal disease?
    Klahr S.
    Semin Nephrol; 1999 May; 19(3):304-9. PubMed ID: 10226337
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Chronic effects of dietary protein in the rat with intact and reduced renal mass.
    Hostetter TH, Meyer TW, Rennke HG, Brenner BM.
    Kidney Int; 1986 Oct; 30(4):509-17. PubMed ID: 3784291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.